Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
4
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
deals
merck
pfizer
aduro biotech
alexion pharmaceuticals
alzheimer's disease
amgen
bristol-myers squibb
cancer immunotherapy
What
bio
roundup
drug
companies
gene
new
patients
plan
price
talk
advantages
alzheimer’s
approval
bar
becker
billions
biogen’s
biopharmaceutical
brings
convo
different
dollars
earlier
eaton
expect
fail
failures
gamble
healthcare
impact
increases
latest
life
littered
market
medco’s
michael
millions
mover
moves
Language
unset
Current search:
medicare
×
novartis
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More